Jung-Chool Kim
Chief Executive Officer bij APROGEN BIOLOGICS INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Jung-Chool Kim is currently the Chief Executive Officer & Director at Aprogen Biologics, Inc. since 2012.
He is also a Director at Aprogen, Inc. and E&M Revolution Co., Ltd.
Additionally, he has previously worked as the Chief Executive Officer at Chunggei Pharm Co. Ltd.
and as a Director at Aprogen, Inc. and Aprogen Biologics, Inc. (Korea).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
APROGEN, INC
0.42% | 12-04-2024 | 1 123 427 ( 0.42% ) | 1 M $ | 31-03-2024 |
APROGEN BIOLOGICS
0.00% | 28-03-2024 | 21 880 ( 0.00% ) | 3 103 $ | 31-03-2024 |
Actieve functies van Jung-Chool Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| APROGEN BIOLOGICS INC. | Chief Executive Officer | 01-04-2012 |
| APROGEN MEDICINES INC. | Director/Board Member | - |
E&M Revolution Co., Ltd.
 E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Director/Board Member | - |
Eerdere bekende functies van Jung-Chool Kim
| Bedrijven | Functie | Einde |
|---|---|---|
Aprogen Biologics, Inc. (Korea)
 Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Director/Board Member | - |
Aprogen, Inc. /Old/
 Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Director/Board Member | - |
| Chunggei Pharm Co. Ltd. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| APROGEN MEDICINES INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| Aprogen Biologics, Inc. | |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Health Technology |
| Chunggei Pharm Co. Ltd. | Health Technology |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Health Technology |
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Health Technology |
